title: Effect of omalizumab in health care workers with occupational latex allergy.
authors.forename: Francisque
authors.initials: F
authors.lastname: Leynadier
authors.forename: Ouafia
authors.initials: O
authors.lastname: Doudou
authors.forename: Hafida
authors.initials: H
authors.lastname: Gaouar
authors.forename: Vincent
authors.initials: V
authors.lastname: Le Gros
authors.forename: Isabelle
authors.initials: I
authors.lastname: Bourdeix
authors.forename: Laurence
authors.initials: L
authors.lastname: Guyomarch-Cocco
authors.forename: Patrick
authors.initials: P
authors.lastname: Trunet
mesh_terms: D000328:Adult; D000485:Allergens / Q000009:adverse effects; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D004311:Double-Blind Method; D005260:Female; D005932:Gloves, Surgical; D006282:Health Personnel; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007840:Latex / Q000009:adverse effects; D020315:Latex Hypersensitivity / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D009784:Occupational Diseases / Q000188:drug therapy* / Q000209:etiology; D016273:Occupational Exposure; D000069444:Omalizumab; D012882:Skin Tests; D016896:Treatment Outcome
chemical_list: D000485:Allergens; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007840:Latex; D000069444:Omalizumab; D007073:Immunoglobulin E